TSH Receptor Antibody (TRAb) Assays Based on the Human Monoclonal Autoantibody M22 are more Sensitive than Bovine TSH Based Assays

Abstract

Measurements of TSH receptor autoantibodies (TRAb) using assays based on the human monoclonal TSH receptor autoantibody M22 or bovine TSH have been compared in 136 adult patients. They suffered from Graves’ disease (GD, n=62), Hashimoto's thyroiditis (HT, n=26), or non-autoimmune hyperthyroidism (NAH, n=48) and were selected on the basis of undetectable, borderline or low TRAb levels (0.6–3 IU/l) as measured by TSH based TRAb assay (Dynotest^® TRAKhuman from BRAHMS). The time interval between initial diagnosis of GD and TRAb determination was high and ranged from 1 month to 3.5 years (median: 2.3 years). Using the kit manufacturer's cutoff values, 53/62 (85.5%) of the selected group of GD patients were TRAb positive (>0.4 IU/l) by M22 based TRAb ELISA (Medizym^® TRAb clone, Medipan) and 45/62 (72.6%) were TRAb positive (>1.5 IU/l) by TSH based TRAb assay. In the HT group, 9/26 (34.6%) sera were positive in the M22 based ELISA and all but one of these 9 were positive or borderline in the TSH based assay. ROC plot analysis of the GD group using the NAH group as reference showed that at 95% specificity, the bovine TSH based TRAb assay had a sensitivity of 62.9% (cutoff for positivity=1.64 IU/l) and the M22 based TRAb ELISA a sensitivity of 90.3% (cutoff for positivity=0.32 IU/l). Overall therefore, the M22 based Medizym^® TRAb clone assay is more sensitive than the bovine TSH based Dynotest^® TRAK human assay.

Key words

thyroid - autoantibodies - TSH receptor - Graves’ disease - Hashimotos’ disease

References

• 1 Rees Smith B, Sanders J, Furmaniak J. TSH receptor antibodies.  Thyroid. 2007;  17 923-938
• 2 Schott M, Scherbaum WA, Morgenthaler NG. Thyrotropin receptor autoantibodies in Graves’ disease.  Trends Endocrinol Metab. 2005;  16 243-248
• 3 Costagliola S, Morgenthaler NG, Hoermann R Badenhoop K, Struck J, Freitag D, Poertl S, Weglöhner W, Hollidt JM, Quadbeck B, Dumont JE, Schumm-Draeger PM, Bergmann A, Mann K, Vassart G, Usadel KH. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves’ disease.  J Clin Endocrinol Metab. 1999;  84 90-97
• 4 Schott M, Feldkamp J, Bathan C, Fritzen R, Scherbaum WA, Seissler J. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation.  Horm Metab Res. 2000;  32 429-435
• 5 Zöphel K, Wunderlich G, Koch R, Franke WG. Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease.  Nuklearmedizin. 2000;  39 113-120
• 6 Zöphel K, von Landenberg P, Roggenbuck D, Wunderlich G, Kotzerke J, Lackner KJ. Are porcine and human TSH receptor antibody measurements comparable?.  Clin Lab. 2008;  54 1-8
• 7 Kamijo K. TSH receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two-step assays, coated plate ELISA using porcine TSH receptor and coated tube radioimmunoassay using human recombinant TSH receptor.  Endocr J. 2003;  50 113-116
• 8 Bolton J, Sanders J, Oda Y, Chapman C, Konno R, Furmaniak J, Rees Smith B. Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA.  Clin Chem. 1999;  45 2285-2287
• 9 Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J, Rees Smith B. Thyroid-stimulating monoclonal antibodies.  Thyroid. 2002;  12 1043-1050
• 10 Sanders J, Evans M, Premawardhana LDKE, Depraetere H, Jeffreys J, Richards T, Furmaniak J, Rees Smith B. Human monoclonal thyroid stimulating autoantibody.  Lancet. 2003;  362 126-128
• 11 Rees Smith B, Bolton J, Young S, Collyer A, Weeden A, Bradbury J, Weightman D, Perros P, Sanders J, Furmaniak J. A new assay for thyrotropin receptor autoantibodies.  Thyroid. 2004;  14 830-835
• 12 Nakatake N, Sanders J, Richards T, Burne P, Barrett C, Dal Pra C, Presotto F, Betterle C, Furmaniak J, Rees Smith B. Estimation of serum TSH receptor autoantibody concentration and affinity.  Thyroid. 2006;  16 1077-1084
• 13 Liu C, Hermsen D, Dornberg J, Graeber C, Hautzel H, Duan Y, Xu KF, Liu CP, Mao XD, Cupisti K, Scherbaum WA, Schott M. Comparison of M22 based ELISA and human TSH receptor based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.  Horm Metab Res. 2008;  40 479-483
• 14 Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays.  Clin Chem. 1996;  42 140-145
• 15 Zweig MH, Campbell G. Receiver-operating characteristic ROC plots: a fundamental evaluation tool in clinical medicine.  Clin Chem. 1993;  39 561-577
• 16 Zöphel K, Grüning T, Roggenbuck D, Wunderlich G, Kotzerke J. On Specificity of 2nd Generation TSH Receptor Autoantibody Measurements.  Clin Lab. 2008;  54 243-249
• 17 Kamijo K, Ishikawa K, Tanaka M. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin based ELISA initiated by Smith.  Endocr J. 2005;  52 525-529
• 18 Kamijo K. TSH receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves’ disease.  Endocr J. 2007;  54 619-624
• 19 Ekins R, Edwards P. On the meaning of sensitivity.  Clin Chem. 1997;  43 1824-1831
• 20 Jensen E, Petersen PH, Blaabjerg O, Hansen PS, Hegedüs L. Improved sensitivity of a thyrotropin receptor antibody assay.  Clin Chem. 2005;  51 2186-2187

Correspondence